Human Papillomavirus Vaccine Hesitancy in the United States

Pediatr Clin North Am. 2023 Apr;70(2):211-226. doi: 10.1016/j.pcl.2022.11.002.

Abstract

Although the US Advisory Committee on Immunization Practices recommends vaccinating adolescents against the human papillomavirus (HPV) to prevent HPV-associated cancers, vaccine initiation and completion rates are suboptimal. Parental and provider hesitancy contributes significantly to low HPV vaccine uptake. This review describes sources of HPV vaccine hesitancy using a World Health Organization framework that categorizes determinants of vaccine hesitancy as follows: contextual factors (historical, sociocultural, environmental, or political factors), individual and group factors (personal perception or influences of the social/peer environment), and vaccine/vaccination-specific issues (directly related to vaccine or vaccination).

Keywords: Adolescent; Human papillomavirus; Parental; Provider; Vaccination; Vaccine beliefs; Vaccine hesitancy.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Health Knowledge, Attitudes, Practice
  • Human Papillomavirus Viruses
  • Humans
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines*
  • United States
  • Vaccination
  • Vaccination Hesitancy

Substances

  • Papillomavirus Vaccines